Qosina: Dip-Molded Plastisol Y Connectors

Manufactured from plastisol, connectors provide flexibility, are Class VI-approved, and are BPA and latex-free.

Manufactured from plastisol, connectors provide flexibility, are Class VI-approved, and are BPA and latex-free.
Manufactured from plastisol, connectors provide flexibility, are Class VI-approved, and are BPA and latex-free.

Qosina stocks a variety of Y connectors manufactured from plastisol, also known as liquid polyvinyl chloride (PVC), a material used to make flexible components. These connectors are produced through a dip molding process rather than traditional injection molding. Plastisol provides exceptional flexibility, is Class VI approved and BPA- and latex-free. Dip molding is said to be an ideal method for molding connectors as the dipping dies are cost-effective, allowing for production to be easily scaled.

Qosina offers both standard and universal plastisol Y connectors. The universal style can be cut to accommodate 3/32 in., 1/8 in., 3/16 inch and ¼ in. OD tubes. With 15 different Y connector configurations from which to choose, sample assortment kits containing a selection of plastisol connectors, and custom design services available, Qosina can provide plastisol connectors to meet the requirements of all types of projects.

Founded in 1980, Qosina is a worldwide supplier of thousands of stock OEM components to the medical and pharmaceutical industries.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?